Otros
Advances in prodrug design
Date
2005-10-01Registration in:
Mini-Reviews in Medicinal Chemistry, v. 5, n. 10, p. 893-914, 2005.
1389-5575
10.2174/138955705774329528
WOS:000231837000003
2-s2.0-24944549193
9734333607975413
0000-0003-4141-0455
Author
Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
Institutions
Abstract
The background of prodrug design is presented herein as the basis for introducing new and advanced latent systems, taking into account mainly the versatility of polymers and other macromolecules as carriers. PDEPT (Polymer-Directed Enzyme Prodrug Therapy); PELT (Polymer-Enzyme Liposome Therapy); CDS (Chemical Delivery System); ADEPT(Antibody-Directed Enzyme Prodrug Therapy); GDEPT/VDEPT (Gene-Directed Enzyme Prodrug Therapy/Virus-Directed Enzyme Prodrug Therapy); ODDS (Osteotropic Drug Delivery System) and LEAPT (Lectin-directed enzyme-activated prodrug therapy) are briefly described and some examples are given. © 2005 Bentham Science Publishers Ltd.
Subjects
Related items
Showing items related by title, author, creator and subject.
-
Potential tuberculostatic agent: Micelle-forming pyrazinamide prodrug
Silva, M.; Ricelli, N. L.; El Seoud, O.; Valentim, C. S.; Ferreira, A. G.; Sato, D. N.; Leitel, CQF; Ferreira, E. I. -
Potential tuberculostatic agents: Micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid
Silva, M.; Lara, A. S.; Leite, CQF; Ferreira, E. I. -
Potential tuberculostatic agents: Micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid
Universidade Estadual Paulista (Unesp); Universidade de São Paulo (USP) (Wiley-Blackwell, 2001-06-01)With the objective of obtaining slow-acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle-forming copolymer of poly(ethylene glycol)-poly(aspartic acid) ...